When a breast implant is placed, the body responds naturally by forming a thin layer of fibrous connective tissue around the implant: the fibrous capsule. In most patients, this capsule remains soft and imperceptible. In a subset of patients, it thickens, calcifies, and contracts — compressing the implant and distorting the shape and texture of the breast. Capsulectomy is the surgical procedure to remove all or part of this fibrous capsule, followed by a joint decision with the patient regarding the fate of the underlying implant.

When a breast implant is placed, the body responds naturally by forming a thin layer of fibrous connective tissue around the implant: the fibrous capsule. In most patients, this capsule remains soft and imperceptible. In a subset of patients, it thickens, calcifies, and contracts — compressing the implant and distorting the shape and texture of the breast. Capsulectomy is the surgical procedure to remove all or part of this fibrous capsule, followed by a joint decision with the patient regarding the fate of the underlying implant.
Breast ultrasound as first-line investigation, supplemented by breast MRI when rupture is suspected or ultrasound is inconclusive. Characterisation of capsule state and implant integrity.
The procedure is performed under general anesthesia.
In most cases, Dr. Fathi uses the existing incision sites from the original implantation — no new scars are added.
Partial capsulectomy (thickened anterior portion) or total en-bloc capsulectomy (entire capsule intact with implant inside, not opened) depending on Baker grade and indication.
Implant extraction according to the chosen technique (partial or en-bloc).
Simple explantation, placement of new modern cohesive implants, or mastopexy to correct secondary breast ptosis.
Moderate chest pain, mandatory surgical support bra.
Swelling and bruising, suture removal at Day 12–14 if non-resorbable.
Significant improvement in comfort, return to light activities.
Progressive tissue softening, visible and stable results.
Scars in maturation phase, final result established.
Results visible and stable from months 1–3. Scar maturation over 6 to 12 months.
After explantation without replacement, breast tissues restructure progressively over 3 to 6 months. Outcome depends on skin quality and implant wear duration. Mastopexy can be scheduled 3 to 6 months after if residual ptosis is noted.
Discover our patients' transformations
Estimated price
Fee upon consultation
Prices shown are estimates and may vary depending on the complexity of your case. A personalized quote will be provided during your consultation.
Warning signs include progressive firmness of one or both breasts, a change in breast shape (higher, rounder, asymmetric), or pain on palpation. Only a consultation with imaging can confirm the diagnosis.
Yes, in the vast majority of cases. Following total capsulectomy and a healing period, placement of new implants is possible. Dr. Fathi evaluates residual tissue quality at consultation.
BIA-ALCL is a rare lymphoma associated primarily with highly textured surface implants. It typically manifests as a late peri-implant seroma. When diagnosed early, it carries an excellent prognosis and is treated with en-bloc capsulectomy.
In most cases, Dr. Fathi uses the existing scars from the original implantation. No additional incisions are required unless a mastopexy is performed simultaneously.
Breast tissues restructure progressively over 3 to 6 months. The outcome depends on skin quality and how long implants were carried. Mastopexy can be scheduled 3 to 6 months after if residual ptosis is noted.
Breast ultrasound is the first-line investigation. MRI is prescribed when rupture is suspected on ultrasound or when findings are inconclusive. MRI is the reference modality for assessing silicone implant integrity.
Chat directly with our team on WhatsApp for a quick and personalized response.